The Business of Eye Innovation podcast

Available Episodes

5 of 21

Episode 21 - What is Happening with MDR?
In this episode of the BOEI Podcast, we discuss what is happening with MDR in Europe . Learn more about our guests: Kristine Morrill - https://www.linkedin.com/in/kamorrill/ Merlin Rietschel - https://www.linkedin.com/company/medtech-europe/ Eric Vollebregt - https://www.linkedin.com/in/erikvollebregt/?originalSubdomain=nl Gert Boss - https://www.linkedin.com/in/gertbos/?originalSubdomain=nl Follow Medevise on LinkedIn.
--------
1:06:59
--------
1:06:59
Episode 20 -The Things We Do Not Talk About in Ophthalmology
On this episode of the BOEI Podcast, Prof Burkhard Dick talks with Kris Morrill about the impact on eyecare from our living longer, as more patients present with neurological diseases including dementia, which is often not diagnosed. > Learn more + key takeaways
--------
32:11
--------
32:11
Episode 19 - The IOL: Celebrating 75 Years
On this episode of the BOEI Podcast, we’re reflecting on the significance of the IOL in modern eye care and the impact created by it’s invention 75 years ago. Together with Tim Clover (CEO fo Rayner), David Lockington (president-elect UKISCRS), and Paul Ursell (incumbent president UKISCRS), we discuss what the IOL has meant for the evolution of eye care, and how our field is celebrating this important innovation. > Learn more + key takeaways
--------
28:10
--------
28:10
Episode 18 - 2024 is the Year of Diversity for ESCRS (An Interview with Dr. Filomena Ribeiro)
On this episode of the BOEI Podcast, we talk with the new president of ESCRS, Dr. Filomena Ribeiro, about the ESCRS Year of Diversity initiative for 2024 and the upcoming Winter Meeting in Frankfurt. Speakers: Kristine Morrill, Founder and President of Medevise Consulting Filomena Ribeiro, President of ESCRS Key Takeaways: 2024 will be the year of promoting diversity and inclusivity for ESCRS Diversity is crucial for ophthalmology and science because: It invites different perspectives and experience, which fuel innovation. It enables our field to mirror the population that it serves, which builds trust with patients and helps to improve outcomes. Minorities are still are under-represented in leadership. For example, the November 2023 issue of JCRS included a survey that found “Females reported a mean of 18% fewer entire [cataract surgical] procedures than their male colleagues and were also less confident in their surgical skills (P< .05).” Greater awareness is needed of the barriers to diversity within ophthalomology, and even more so in surgical ophthalomology, such as the need for parental leave. To establish a baseline for diversity within the society and the field, ESCRS will conduct a membership survey in early 2024. This will also enable the measurement of future improvements. The US-based think tank Project Implicit (led by scientists from Harvard University and the University of Virginia) is working with ESCRS on assessing unconscious bias. Project Implicit has developed an online assessment tool to help individuals identify and understand their own unconscious bias – it can be found here: https://implicit.harvard.edu/implicit/takeatest.html The ESCRS annual meeting in Barcelona in September 2024 will include a symposium on diversity and inclusion, where Project Implicit will offer a workshop. ESCRS Winter Meeting – February 2024, Frankfurt This year’s winter meeting is a joint meeting with the German Cataract and Refractive Surgeons Society (DGII) The program for this meeting is designed as a more focused, more immersive learning program with greater opportunities for networking and interaction. There are two main tracks: refractive intraocular surgery and corneal refractive surgery. The medical writing workshop that debuted at ESCRS annual congress 2023 in Vienna will return for both the winter meeting in Frankfurt and the annual congress in Barcelona in September. Round tables will offer small group interaction Escape room activities will be offered as a fun ice-breaker and interactive activity for delegates Learn more about the ESCRS 2024 Winter Meeting, where more details and plans for the upcoming Year of Diversity will be announced. Follow Medevise on LinkedIn.
--------
18:32
--------
18:32
Episode 17 - American Companies Doing Business in France
On this episode of the BOEI Podcast, we’re talking about Americans doing business in France. Specifically, what American medtech and healthcare businesses should consider when weighing a location in the region of Alsace. We are joined by three American professionals who each have deep experience working and growing businesses in France. Together they’re discussing the cultural, logistic, and talent aspects of doing business here, from the perspective of Americans and American businesses. Speakers: Kristine Morrill, Founder and President of Medevise Consulting Patricia Hatesuer, senior health advisor for Invest Eastern France Darragh Paradiso, (former) US Consulate General Strasbourg Renée Meyer, French-American expert for medtech Key Takeaways: What is unique about the international business environment in Alsace, specifically for the health sector? The BioValley cluster is one of Europe’s major centers for life science companies Strong access to talent in the Upper Rhine Valley, where there are an estimated 32,000 people working in the life science sector (compared to 4,000 in London, and 20,000 in Paris). Alsace has been a cradle of biotech and pharma since the 1990’s. At the University of Strasbourg, there are five Nobel Prize winners in medicine, chemistry or related. US companies employ 23,000 people in the region, and 200 American companies are present in the region. Invest Eastern France is one of the top incubators in France for the health sector. France offers competitive tax credits for R&D and innovation expenditures for start-ups and new businesses Border region This region benefits from the multicultural influences, a sense of openness to others, and multiple languages and cultural influences. It’s also key for market access: This region borders Germany, Switzerland, Belguim, and Luxeumbourg – 48% of the European MedTech market is centered in these five countries (including France). Is there a language a barrier? While knowing French is helpful, its not always necessary. There are several American companies in this region headed by people who do not speak French, and they manage. Many people in this region are comfortable with English, as it is taught in school. This is more common in the cities like Strasbourg (less so in the villages), as residents are used to living alongside many foriegners from the European Parliament, the Council of Europe, international students and businesses. There are several international school options in the region with resources to help children learn French. Logistics Rhenus Logistics Alsace is a dedicated warehouse to pharmaceutical and medical device located on the border with Germany. Their ability to get across Europe and into the Middle East is unmatched. Transport access includes the active Port of Strasbourg; an extensive train system with a connection to Paris in less than 2 hours; trams that connect Strasbourg to Kehl, Germany; and the second largest network of bike paths in Europe. Cultural connections between US and France France is the US’s oldest ally. They helped us during our War of Independence, and we helped France during the World Wars. As a result, the friendship and the ties are deep and very diverse. The second largest M&M factory in the world is just 12 miles north of Strasbourg. Kobe Bryant lived in Strasbourg as a kid, when his dad played for French basketball. Basketball is popular here, and the SIG team in Strasbourg usually has a roster that’s about half American. Learn more about our guests Patricia Hatesuer, senior health advisor for Invest Eastern France; Darragh Paradiso, (former) US Consulate General Strasbourg; and Renée Meyer, French-American expert for medtech.
--------
39:27
--------
39:27